-
CASCADE metastatic melanoma study
Study
EGAS00001004950
-
Targeted_sequencing_of_cylindroma_patients
Study
EGAS00001002708
-
Glioblastoma initiating cells are sensitive to histone demethylase inhibition due to epigenetic deregulation
Study
EGAS00001003750
-
whole-genome sequencing in 17 ESCC cases and whole-exome sequencing in 71 cases
Study
EGAS00001000709
-
DIPG RNA and exome sequencing
Study
EGAS00001004749
-
CAF-S3 subset in human breast and ovarian cancers
Study
EGAS00001003344
-
Gene expression profile of mesothelial-derived carcinoma-associated fibroblasts
Study
EGAS00001003747
-
NRG1 Fusions in KRAS Wild-type Pancreatic Cancer (H021)
Study
EGAS00001002759
-
Identification of rare germline variants in familial multiple myeloma
Study
EGAS00001004734
-
Growth Hormone (GH) -secreting Pituitary Adenoma
Study
EGAS00001003488
-
Dynamics of genome architecture and chromatin function during human B cell differentiation and neoplastic transformation
Study
EGAS00001004763
-
Targeted panel data for newly diagnosed myeloma patients.
Study
EGAS00001002859
-
Normal brain controls for ICGC PedBrain DNA methylation sequencing
Study
EGAS00001000909
-
RNAseq of 76 samples from Uveal Melanoma tumors
Study
EGAS00001002932
-
Genomics_of_acral_lentiginous_melanoma___RNAseq
Study
EGAS00001003758
-
Alveolar Rhabdomyosarcoma case report
Study
EGAS00001004828
-
The_contribution_of_POT1_variants_to_sporadic_melanoma_development
Study
EGAS00001001964
-
Identification of recurrent mutations in Cushing’s disease
Study
EGAS00001003029
-
Immune trajectory of response and adverse effect in immunotherapy-treated hepatocellular carcinoma
Study
EGAS00001004843
-
Whole genome and whole transcriptome sequencing of Hepatosplenic T Cell Lymphoma tumor.
Study
EGAS00001003775
-
Genetic analysis of HLA and immune escape genes in Diffuse Large B-cell Lymphoma
Study
EGAS00001005054
-
Mutational analysis of an oligoprogressive sarcomatoid hepatocellular carcinoma treated with an immune checkpoint inhibitor.
Study
EGAS00001005064
-
Melanoma_brain_metastases
Study
EGAS00001002107
-
ARAF Mutations Confer Resistance to RAF Dimer Inhibitor Belvarafenib in NRAS- and BRAF- Mutant Melanoma
Study
EGAS00001005086
-
HDAC inhibitors in synovial sarcoma cells
Study
EGAS00001002637